animalcaregroup.co.uk valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Animalcare Group plc - |
| Description | We Are Animalcare develops and supplies veterinary pharmaceutical products and services to support the veterinary profession in seven European |
| Keywords | veterinary,pharmaceutical |
Server Information
| WebSite | |
| Host IP | 85.233.160.22 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
animalcaregroup.co.uk Valuation
|
US$910
Last updated: 2023-05-13 16:54:58
animalcaregroup.co.uk has Semrush global rank of 0. animalcaregroup.co.uk has an estimated worth of US$ 910, based on its estimated Ads revenue. animalcaregroup.co.uk receives approximately 105 unique visitors each day. Its web server is located in United Kingdom, with IP address 85.233.160.22. According to SiteAdvisor, animalcaregroup.co.uk is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$910 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$25 |
| Yearly Ads Revenue | US$302 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| animalcaregroup.co.uk. | A | 86400 | IP: 85.233.160.22 |
| animalcaregroup.co.uk. | NS | 86400 | NS Record: ns1.phase8.net. |
| animalcaregroup.co.uk. | NS | 86400 | NS Record: ns0.phase8.net. |
| animalcaregroup.co.uk. | NS | 86400 | NS Record: ns2.phase8.net. |
| animalcaregroup.co.uk. | MX | 86400 | MX Record: 10 animalcaregroup-co-uk.mail.protection.outlook.com. |
| animalcaregroup.co.uk. | TXT | 3600 | TXT Record: MS=ms85046201 |
| animalcaregroup.co.uk. | TXT | 86400 | TXT Record: animalcare-wwwanimalcaregroupcouk.azurewebsites.net |
| animalcaregroup.co.uk. | TXT | 86400 | TXT Record: v=spf1 include:servers.mcsv.net include:spf.protection.outlook.com include:spf.mtaroutes.com include:spf.mailanyone.net -all |
| animalcaregroup.co.uk. | TXT | 86400 | TXT Record: bbeim6aaks5kk9unfn9iiea15q |
HtmlToTextCheckTime:2023-05-13 16:54:58
| Financial sustainability through revenue growth, strong cash conversion, EPS growth and EBITDA margin growth Revenue growth key initiatives Focus on segments and products with highest potential New product launches Leverage strengths across all our direct markets Maximise opportunities in other high growth markets through partnerships or selective acquisition progress New product sales of £2.2m (2020: £2.2m) Successful launch of Daxocox in H2, contributing £1.2m in revenue 8.3% growth in revenue generated by top 40 products in portfolio 2022 priorities Continue to scale up in fast-growing countries Maximise growth potential of Daxocox in dynamic market Successful launch of STEM biofilm dental range in H1 Cash conversion and net debt key initiatives Maintain net debt to underlying EBITDA leverage ratio between 1 to 2 times Optimise inventory Tax efficiency progress Strong underlying cash conversion of 108.8% £5.3m net debt at year end; reduced by 60% over course of 2020 Net debt |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Tue, 21 Dec 2021 19:00:42 GMT Server: Apache Location: https://www.animalcaregroup.com/ Content-Type: text/html; charset=UTF-8 HTTP/2 200 cache-control: private content-length: 48588 content-type: text/html; charset=utf-8 x-frame-options: sameorigin x-content-type-options: nosniff strict-transport-security: max-age=10886400 x-xss-protection: 1; mode=block set-cookie: ARRAffinity=7ee8c6c6b6d031cd3e123132082eb4936faef8fb7cebf12ea0c7eeb3f609836e;Path=/;HttpOnly;Secure;Domain=www.animalcaregroup.com set-cookie: ARRAffinitySameSite=7ee8c6c6b6d031cd3e123132082eb4936faef8fb7cebf12ea0c7eeb3f609836e;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.animalcaregroup.com date: Tue, 21 Dec 2021 19:00:42 GMT |